☀ Trending Among Corona Carnage ☀ List of Best Performing Corona Vaccine Stocks, Tech Penny Stocks, Healthcare Stocks, and Artificial Intelligence Stocks. Drugs, healthcare services and medical devices continue to remain the most fundamental need of humans as well as any other living creatures that may have access to them. The larger healthcare industry, which is now estimated to be worth around $300 trillion, serves this basic requirement. Hundreds of healthcare companies have listed their stocks for active trading on the leading stock exchanges across the globe. It allows a convenient channel to short term traders as well as long term investors to take a shot at the performance of such healthcare companies with an aim to generate profits. Among the several healthcare companies whose stocks are listed and actively trading on the stock exchanges, which have been the winners in terms of highest returns? This article provides a list of healthcare stocks that have given the top returns in the year 2021 till date of writing. The list is prepared based on the percentage returns generated by the individual healthcare stocks between the end of the previous and Jul 12, 2021, and the top 10 return generating healthcare stocks are listed below.
Best Performing Stock Screener:
This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.
The following list presents stocks of the companies which belong to the broader Healthcare sector or the stock market index, their corresponding prices as of given date, and the percentage gains realized: 1) KemPharm, Inc. (KMPH)
Here's a look at the basic details and how the above mentioned stocks fared during the period:
KemPharm, Inc., incorporated on May 28, 2014, is a clinical-stage specialty pharmaceutical company. The Company is engaged in the discovery and development of prodrugs. The Company uses its Ligand Activated ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of KemPharm. The Iowa, IA-headquartered company KemPharm, Inc. (KMPH) is ranked number one among the best performing stocks of Healthcare of 2021. The Healthcare sector business falls under the Major Pharmaceuticals industrial sub-sector. Since the start of the year 2021, the stock price of KemPharm has changed by 1736.11 percent, which is calculated based on the previous year's closing price of $0.72 per share and year-to-date closing price of $13.22 per share as of writing. The market value of the company as indicated by its market-cap changed from $3.27 million to $448.08 million during the same period. Along with Healthcare, the company is also in the business of Health Care, Major Pharmaceuticals, Biotechnology, Biotech, Wilshire 5000, among other usual products and services. KemPharm continues to be a leading constituent of many major stock market indexes like Wilshire 5000 index, and a few other larger indexes which are part of the stock market.
Annovis Bio, Inc., a clinical stage drug platform company, focuses on developing compounds to address neurodegeneration. The company's lead compound is ANVS-401, which is in Phase 2a clinical trials for the treatment of chronic neurodegenerative diseases, such as Down syndrome, Alzheimer's disease (AD), and Parkinson's disease. It is also developing ANVS-301, a compound in Phase 1 clinical trials to in ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Annovis Bio. Based on the market-cap change from $51.96 million to $814.64 million during the given months of the year 2021 and the share price change from $7.54 per share to a price of $117.26 per share as of Jul 12, 2021, Annovis Bio, Inc. (ANVS) was successful in generating YTD returns of 1455.17 percentage. Standing at the number two rank in the top performing list of Healthcare stocks, the Berwyn, PA-based Annovis Bio is categorized as the Biotechnology sub-sector business which falls under the larger Healthcare sector.
Cassava Sciences, Inc.
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Cassava Sciences, Inc.. During the given months of the year 2021, Cassava Sciences, Inc. (SAVA) was successful in generating YTD returns of 1356.3 percentage which helped it gain the number three spot in the list of the top performing stocks which generated maximum returns during year 2021 till date. As of December of the previous year, the stock of the Austin, United States-based Cassava Sciences, Inc. closed at a price of $6.82 per share, while it traded at a price of $99.32 per share as of Jul 12, 2021. The company's market cap changed from $0 million to $3.97 billion during the same period YTD. The company is classified under the Healthcare industry sector and further specialized as a Major Pharmaceuticals sector business.
Onconova Therapeutics, Inc., incorporated on December 22, 1998, is a clinical-stage biopharmaceutical company. The Company operates through the identification and development of oncology therapeutics segment. It is focused on discovering ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Onconova Therapeutics. The Pennsylvania, PA-based Healthcare sector company Onconova Therapeutics, Inc. (ONTX) holds the number four spot among the best performing stocks of the Healthcare sector. Classified as the Major Pharmaceuticals business, the stock price of Onconova Therapeutics ended the previous year at a price of $0.47 per share while it reached the level of $5.98 apiece as of Jul 12, 2021 translating to a percentage change in stock price of 1183.81%. As of writing, the company's market-cap value stands at $94.37 million. Few leading stock market index includes Onconova Therapeutics in their constituent list. They include Wilshire 5000 index, and a few other larger indexes which are part of the stock market.
Novan, Inc. is a late-stage pharmaceutical company. The Company is engaged in the development and commercialization of therapies using its nitric oxide platform. The Company develops product candidates using its ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Novan. Rank number five in the coveted list is held by Novan, Inc. (NOVN) for being among the top performing stocks of 2021. Headquartered in North Carolina, NC, the Healthcare sector company is categorized under the industrial sub-sector of Major Pharmaceuticals. Since the start of the year 2021, stock of Novan has so far gained 1015.62 percentage, based on the previous year's closing price of $0.81 per share and year-to-date price of $9.07 per share. During the same period, the market capitalization of the company changed from $115.05 million to $170.58 million.
Acorda Therapeutics, Inc., incorporated on March 17, 1995, is a biopharmaceutical company. The Company focuses on developing therapies that restore function and improve the lives of people with neurological disorders. ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Acorda Therapeutics. At number six in the list of top stocks stands Acorda Therapeutics, Inc. (ACOR), which saw a change in its stock price from the level of $0.69 apiece during previous year December end to the price of $4.22 per share as of Jul 12, 2021. It translates to a change of 511.51 percentage. The New York, NY-headquartered Healthcare sector company also saw its market value change from $39.25 million to $46.95 million. The Biotech Biological Products specialist also managed to outperform some of the major stock market indexes of which it is a part of. They include the Wilshire 5000 index, and a handful of other multi-capitalization indexes.
Atossa Genetics Inc., incorporated on April 30, 2009, is a clinical-stage pharmaceutical company focused on the development of therapeutics and delivery methods for the treatment of breast cancer and other ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Atossa Genetics. Atossa Genetics Inc. (ATOS) has moved by 488.42 percentage over the given period of 2021-YTD, helping it gain a place at number seven among the top performing stocks. The Healthcare sector company managed to achieve the feat as its stock price changed from $0.95 apiece to the price of $5.59 per share between the end of December of the previous year and Jul 12, 2021. The smart run of the Washington, WA-based Medical Dental Instruments sector company lead to a handsome gain in its marketcap which changed from $37.11 million to $675.41 million over the same duration. Atossa Genetics is a key member of many popular stock market indexes. They include Wilshire 5000 index, and several other broader level multi-cap market indicators.
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Entera Bio. The Jerusalem, -based Entera Bio Ltd. (ENTX) belongs to the Healthcare sector and is categorized as a Healthcare company. The stock of Entera Bio ended the previous year at a price of $1.08 per share. As of Jul 12, 2021, the stock price has reached $5.75 apiece, which indicates a change of 432.41 percent making the company rank among the top performing stocks of the Healthcare for the year 2021 till date. At the end of the last year, company's market capitalization stood at $19.83 million. It has now changed to $136.72 million as of writing.
Apollo Medical Holdings, Inc.
Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare management company, provides medical care services. The company is ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Apollo Medical Holdings, Inc.. Apollo Medical Holdings, Inc. (AMEH) generated percentage returns of 398.69 percent during the 2021 year-to-date. Its returns are based on the share price which moved from $18.27 per share from the previous year-end to the price of $91.11 per share as of Jul 12, 2021. The company's value, as indicated by the market-cap figure, changed from $0 million to $5.01 billion during the same period. The company is categorized as a Healthcare speciality business with further classification in the Medical Care Facilities sub-category. Based in Alhambra, United States, the YTD performance of the Healthcare sector also fared better than that of the returns generated by some of the closley tracked stock market indexes.
PDS Biotechnology Corporation
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of PDS Biotechnology Corporation. The number ten spot in the list of top performing stocks of the Healthcare sector is taken by PDS Biotechnology Corporation (PDSB). The company's stock price changed from $2.14 per share at the end of December of the previous year to the price of $10.02 per share as of writing. Overall, the stock managed to realized price change of 368.22 percent during the given time period. The corresponding change in the market capitalization value of the Florham Park, United States-based Healthcare sector company was from $0 million to $284.23 million. Being ranked in the top 10 best performing stocks of the Healthcare sector, the company also succeeded in outperforming the returns generated by some of the popular stock market indexes.This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.